Table 2.

Characteristics of patients with positive anti-RNAP III–155 antibody.

Case 1	20-year old male patient with limited cutaneous involvement, RP, joint and tendon involvement. Disease duration: 5 years. ANA titer 1:320, AC-5. The patient has received vasodilators in the last 6 months. Capillaroscopic examination revealed normal pattern.
Case 2	64-year old female patient with diffuse cutaneous involvement, RP, pulmonary involvement. Disease duration: 14 years. ANA titer 1:320, AC-5. The patient has received therapy with cyclophosphamide and corticosteroids in the last 6 months. The patient has received vasodilators, anti-platelet drug, and D-penicillamin in the last 6 months. Capillaroscopic examination revealed normal pattern.
Case 3	57-year old female patient with limited cutaneous involvement, RP, joint and tendon involvement. Disease duration: 13 years. ANA titer 1:160, AC-5. Capillaroscopic examination revealed “early” pattern.
Case 4	32-year old female patient with limited cutaneous involvement, RP, joint and tendon involvement. Disease duration: 15 years. ANA titer 1:1280, AC-5, AC-10. The patient has received vasodilators in the last 6 months. Capillaroscopic examination revealed normal pattern.